Processa raises $1.3M in private placement; evaluating crypto treasury strategy

Processa Pharmaceuticals, Inc.

Sold 5,467,181 restricted shares at $0.23/share for ~$1.3M gross proceeds.
Placement agent LifeSci Capital receives 7% cash fee; offering closed August 6, 2025.
Net proceeds for general corporate purposes; company evaluating corporate cryptocurrency treasury strategies.
Crypto strategy aims to diversify capital base, reduce dilution, and fund clinical programs.

item 1.01item 3.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.